Contract Pharmaceuticals CCAA proceedings and sale to Aterian Investment Partners

Goodmans LLP acted as counsel to Contract Pharmaceuticals Limited and its affiliates in connection with their CCAA proceedings and other restructuring activities.

As part of the recapitalization, Contract Pharmaceuticals was acquired by AIP Elixir Buyer Inc., an affiliate of Aterian Investment Partners IV, LP, emerging from CCAA protection as a well-funded business with a right-sized capital structure that has an exciting future ahead of it.

Contract Pharmaceuticals Limited Canada is a leading North American contract development and manufacturing organization of non-sterile liquid and semi-solid dosage forms.